Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial - Fuchs, CS; Tomasek, J; Yong, CJ (Lancet, 2014)
et al.